Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050202 · ClinicalTrials.gov registry record · NA
Attachment and Biobehavioral Catch-up for Depression
A NA study of Depressive Symptoms and Anxiety Symptoms, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT04050202: Completed NA study of Depressive Symptoms and Anxiety Symptoms, sponsored by University of California, San Francisco.
NCT04050202 is a NA study of Depressive Symptoms and Anxiety Symptoms that has completed, run by University of California, San Francisco. The registered enrollment target is 42 participants, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04050202, a NA study of Depressive Symptoms and Anxiety Symptoms, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal is to pilot the Attachment and Biobehavioral Catch-up (ABC) intervention for mothers with heightened depressive symptom and their children with heightened internalizing symptoms.
Primary Outcome
The internalizing subscale of the CBCL is a validated measure of emotional withdrawal, reactivity, sadness, anxiety, and other symptoms completed by mothers about their children. Scores range from 0 to 72 with higher scores indicating more severe symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Attachment and Biobehavioral Catch-up (ABC) Intervention
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT04050202 record still lists
NCT04050202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Attachment and Biobehavioral Catch-up (ABC) Intervention is the first listed.
NCT04050202 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04050202 about?
NCT04050202 is a clinical study titled "Attachment and Biobehavioral Catch-up for Depression". The overarching goal is to pilot the Attachment and Biobehavioral Catch-up (ABC) intervention for mothers with heightened depressive symptom and their children with heightened internalizing symptoms.
What is the current status of trial NCT04050202?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2020-08-01. Estimated completion is 2022-09-30.
What conditions does trial NCT04050202 study?
This clinical trial studies the following conditions: Depressive Symptoms, Anxiety Symptoms.
What interventions are being tested in trial NCT04050202?
The interventions under investigation include: Attachment and Biobehavioral Catch-up (ABC) Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04050202?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04050202 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04050202's enrollment target sits among peer trials
42 52nd of 60 higher than 9 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI